Carla Nester, MD, MSA, FASN

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Novartis
    Topic:
    C3 Glomerulopathy
    Date added:
    01/26/2024
    Date updated:
    01/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Apellis
    Topic:
    C3 Glomerulopathy
    Date added:
    01/26/2024
    Date updated:
    01/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Kira
    Topic:
    C3 Glomerulopathy
    Date added:
    01/26/2024
    Date updated:
    01/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Achillion
    Topic:
    C3 Glomerulopathy
    Date added:
    01/26/2024
    Date updated:
    01/29/2024
    Relationship end date:
    08/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Biocryst
    Topic:
    C3 Glomerulopathy
    Date added:
    01/26/2024
    Date updated:
    01/29/2024
    Relationship end date:
    01/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    ChemoCentryx
    Topic:
    ANCA
    Date added:
    01/29/2024
    Date updated:
    01/29/2024
    Relationship end date:
    03/15/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Retrophin
    Topic:
    FSGS
    Date added:
    01/29/2024
    Date updated:
    01/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Silence Therapeutics
    Topic:
    PNH
    Date added:
    01/29/2024
    Date updated:
    01/29/2024
    Relationship end date:
    08/08/2023
Return to NCHFL PGR | An Old and a New Look at C3 Glomerulopathy